AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 78(5), 2008, pp. 702-709
Copyright © 2008 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Meltzer, E.
Right arrow Articles by Schwartz, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meltzer, E.
Right arrow Articles by Schwartz, E.

Eosinophilia Among Returning Travelers: A Practical Approach

Eyal Meltzer, Ruth Percik, Joshuah Shatzkes, Yehezkel Sidi, AND Eli Schwartz*
Center for Geographic Medicine and Department of Medicine C, Sheba Medical Center, Tel Hashomer, Israel; the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Internal Medicine, Yale-New Haven Hospital, New Haven, Connecticut

Eosinophilia is not uncommon among returning travelers; however, the optimal diagnostic and therapeutic approach in travelers, as opposed to immigrants and refugees, is not clearly established. This was a retrospective case series. All returning travelers from developing countries presenting at the post-travel clinic with eosinophilia (≥ 500 cells/mcl) during 1994–2006 were evaluated. Data were compared with other referrals to the post-travel clinic and with a random sample of a pre-travel clinic. Of the 955 returning travelers evaluated during the study period, 82 (8.6%) had eosinophilia, and 44 (4.4%) were diagnosed with schistosomiasis. Another 38 (4.2%) cases presented with non-schistosomal eosinophilia (NSE), among whom a definite parasitologic diagnosis was achieved in only 23.7%. However, an empiric course of albendazole led to a clinical improvement in 90% of NSE cases. Helminthic disease probably accounts for the majority of cases of post-travel eosinophilia. Empiric albendazole therapy should be offered to undiagnosed NSE patients.

Received September 17, 2007. Accepted for publication January 3, 2008.

* Address correspondence to Eli Schwartz, The Center for Geographic Medicine and Department of Medicine C, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel. E-mail: elischwa{at}post.tau.ac.il

Authors’ addresses: Eli Schwartz, The Center for Geographic Medicine and Department of Medicine C, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel, Fax: 972-3-5302011, E-mail: elischwa{at}post.tau.ac.il. Eyal Meltzer, The Infectious Disease Unit and Department of Medicine C, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel, Telephone: 972-54-4728552, Fax: 972-3-5303501, E-mail: emeltzer{at}post.tau.ac.il. Ruth Percik, Department of Medicine C, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel, Fax: 972-3-5302011, E-mail: ruth_percik{at}yahoo.com. Joshuah Shatzkes, The Department of Internal Medicine, Yale-New Haven Hospital, New Haven, CT, E-mail: Joshua.shatzkes{at}yale.edu. Yehezkel Sidi, Department of Medicine C, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel, Fax: 972-3-5302011, E-mail: ysidi{at}sheba.health.gov.il.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Tropical Medicine and Hygiene.